Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIST trial of individualized FSH dosing for IVF
NL-OMON38129Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of follicle-stimulating hormone in infertility and hypofertility (4 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Live birth and Costs. Started May 2011; status: active, not recruiting.
02
Drugs
follicle-stimulating hormone
03
Conditions
infertilityhypofertility
Beyond the preview
Go deeper on NL-OMON38129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38129.